NorthCoast Asset Management’s Edwards Lifesciences EW Stock Holding History

NorthCoast Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$3.16M	Buy	27,937 +547	+2%	+$62.4K	0.12%	139
2021 Q2	$2.84M	Buy	27,390 +1,759	+7%	+$166K	0.1%	152
2021 Q1	$2.14M	Buy	25,631 +33	+0.1%	+$2.79K	0.09%	162
2020 Q4	$2.33M	Sell	25,598 -159,936	-86%	-$13.3M	0.11%	126
2020 Q3	$14.8M	Sell	185,534 -47,632	-20%	-$3.72M	0.75%	49
2020 Q2	$16.1M	Sell	233,166 -17,661	-7%	-$1.26M	0.92%	36
2020 Q1	$15.8M	Buy	+250,827	New	+$18.1M	1.01%	35

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

NorthCoast Asset Management's EW Position: Q3 2021 in Review

NorthCoast Asset Management increased its Edwards Lifesciences (EW) stake by 2% in Q3 2021, buying an estimated $62.4K and bringing the position to 27,937 shares worth $3.16M. The position accounts for 0.12% of the portfolio, ranked #139.

NorthCoast Asset Management first reported a position in EW in Q1 2020 and has held it in 7 quarters since. The position peaked at $16.1M in Q2 2020. 1,228 funds tracked by Wall St. Rank hold EW as of Q3 2021.

NorthCoast Asset Management held 27,937 shares of Edwards Lifesciences worth $3.16M as of Q3 2021.
NorthCoast Asset Management bought 547 Edwards Lifesciences shares in Q3 2021, an estimated $62.4K.
Edwards Lifesciences made up 0.12% of NorthCoast Asset Management's portfolio in Q3 2021, its #139 holding.
NorthCoast Asset Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 7 quarters since.
NorthCoast Asset Management's Edwards Lifesciences position peaked at $16.1M in Q2 2020.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.